| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Illinois Insurance Code is amended by | |||||||||||||||||||
5 | changing Section 356z.4 as follows:
| |||||||||||||||||||
6 | (215 ILCS 5/356z.4)
| |||||||||||||||||||
7 | Sec. 356z.4. Coverage for contraceptives.
| |||||||||||||||||||
8 | (a) The General Assembly hereby finds and declares all of | |||||||||||||||||||
9 | the following: | |||||||||||||||||||
10 | (1) Illinois has a long history of expanding timely | |||||||||||||||||||
11 | access to birth control to prevent unintended pregnancy. | |||||||||||||||||||
12 | (2) The federal Patient Protection and Affordable Care | |||||||||||||||||||
13 | Act includes a contraceptive coverage guarantee as part of | |||||||||||||||||||
14 | a broader requirement for health insurance to cover key | |||||||||||||||||||
15 | preventive care services without out-of-pocket costs for | |||||||||||||||||||
16 | patients. | |||||||||||||||||||
17 | (3) The General Assembly intends to build on existing | |||||||||||||||||||
18 | State and federal law to promote gender equity and women's | |||||||||||||||||||
19 | health and to ensure greater contraceptive coverage equity | |||||||||||||||||||
20 | and timely access to all federal Food and Drug | |||||||||||||||||||
21 | Administration approved methods of birth control for all | |||||||||||||||||||
22 | individuals covered by an individual or group health | |||||||||||||||||||
23 | insurance policy in Illinois. |
| |||||||
| |||||||
1 | (4) Medical management techniques such as denials, | ||||||
2 | step therapy, or prior authorization in public and private | ||||||
3 | health care coverage can impede access to the most | ||||||
4 | effective contraceptive methods. | ||||||
5 | (b) As used in this Section: | ||||||
6 | "Contraceptive services" includes consultations, | ||||||
7 | examinations, procedures, and medical services, provided on an | ||||||
8 | outpatient basis and related to the use of contraceptive | ||||||
9 | methods (including natural family planning) to prevent an | ||||||
10 | unintended pregnancy. | ||||||
11 | "Medical necessity" includes, but is not limited to, | ||||||
12 | considerations such as severity of side effects, differences in | ||||||
13 | permanence and reversibility of contraceptive, and ability to | ||||||
14 | adhere to the appropriate use of the item or service, as | ||||||
15 | determined by the attending provider. | ||||||
16 | "Therapeutic equivalent version" means drugs, devices, or | ||||||
17 | products that can be expected to have the same clinical effect | ||||||
18 | and safety profile when administered to patients under the | ||||||
19 | conditions specified in the labeling and satisfy the following | ||||||
20 | general criteria: | ||||||
21 | (1) they are approved as safe and effective; | ||||||
22 | (2) they are pharmaceutical equivalents in that they | ||||||
23 | (A) contain identical amounts of the same active drug | ||||||
24 | ingredient in the same dosage form and route of | ||||||
25 | administration and (B) meet compendial or other applicable | ||||||
26 | standards of strength, quality, purity, and identity; |
| |||||||
| |||||||
1 | (3) they are bioequivalent in that (A) they do not | ||||||
2 | present a known or potential bioequivalence problem and | ||||||
3 | they meet an acceptable in vitro standard or (B) if they do | ||||||
4 | present such a known or potential problem, they are shown | ||||||
5 | to meet an appropriate bioequivalence standard; | ||||||
6 | (4) they are adequately labeled; and | ||||||
7 | (5) they are manufactured in compliance with Current | ||||||
8 | Good Manufacturing Practice regulations. | ||||||
9 | (c) (a) An individual or group policy of accident and | ||||||
10 | health insurance amended,
delivered, issued, or renewed in this | ||||||
11 | State after the effective date of this amendatory Act of the | ||||||
12 | 99th General Assembly shall provide coverage for all of the | ||||||
13 | following services and contraceptive methods: | ||||||
14 | (1) All contraceptive drugs, devices, and other | ||||||
15 | products approved by the United States Food and Drug | ||||||
16 | Administration. This includes all over-the-counter | ||||||
17 | contraceptive drugs, devices, and products approved by the | ||||||
18 | United States Food and Drug Administration. The following | ||||||
19 | apply: | ||||||
20 | (A) If the United States Food and Drug | ||||||
21 | Administration has approved one or more therapeutic | ||||||
22 | equivalent versions of a contraceptive drug, device, | ||||||
23 | or product, a policy is not required to include all | ||||||
24 | such therapeutic equivalent versions in its formulary, | ||||||
25 | so long as at least one is included and covered without | ||||||
26 | cost-sharing and in accordance with this Section. |
| |||||||
| |||||||
1 | (B) If an individual's attending provider | ||||||
2 | recommends a particular service or item approved by the | ||||||
3 | United States Food and Drug Administration based on a | ||||||
4 | determination of medical necessity with respect to | ||||||
5 | that individual, the plan or issuer must cover that | ||||||
6 | service or item without cost sharing. The plan or | ||||||
7 | issuer must defer to the determination of the attending | ||||||
8 | provider. | ||||||
9 | (C) If a drug, device, or product is not covered, | ||||||
10 | plans and issuers must have an easily accessible, | ||||||
11 | transparent, and sufficiently expedient process that | ||||||
12 | is not unduly burdensome on the individual or a | ||||||
13 | provider or other individual acting as a patient's | ||||||
14 | authorized representative to ensure coverage without | ||||||
15 | cost sharing. | ||||||
16 | (D) This coverage must provide for the dispensing | ||||||
17 | of 12 months' worth of contraception at one time. | ||||||
18 | (2) Voluntary sterilization procedures. | ||||||
19 | (3) Contraceptive services, patient education, and | ||||||
20 | counseling on contraception. | ||||||
21 | (4) Follow-up services related to the drugs, devices, | ||||||
22 | products, and procedures covered under this Section, | ||||||
23 | including, but not limited to, management of side effects, | ||||||
24 | counseling for continued adherence, and device insertion | ||||||
25 | and removal. | ||||||
26 | (d) A policy subject to this Section shall not impose a |
| |||||||
| |||||||
1 | deductible, coinsurance, copayment, or any other cost-sharing | ||||||
2 | requirement on the coverage provided pursuant to this Section. | ||||||
3 | (e) Except as otherwise authorized under this Section, a | ||||||
4 | policy shall not impose any restrictions or delays on the | ||||||
5 | coverage required under this Section. | ||||||
6 | this
amendatory Act of the 93rd General Assembly that provides | ||||||
7 | coverage for
outpatient services and outpatient prescription | ||||||
8 | drugs or devices must provide
coverage for the insured and any
| ||||||
9 | dependent of the
insured covered by the policy for all | ||||||
10 | outpatient contraceptive services and
all outpatient | ||||||
11 | contraceptive drugs and devices approved by the Food and
Drug | ||||||
12 | Administration. Coverage required under this Section may not | ||||||
13 | impose any
deductible, coinsurance, waiting period, or other | ||||||
14 | cost-sharing or limitation
that is greater than that required | ||||||
15 | for any outpatient service or outpatient
prescription drug or | ||||||
16 | device otherwise covered by the policy. (b) As used in this | ||||||
17 | Section, "outpatient contraceptive service" means
| ||||||
18 | consultations, examinations, procedures, and medical services, | ||||||
19 | provided on an
outpatient basis and related to the use of | ||||||
20 | contraceptive methods (including
natural family planning) to | ||||||
21 | prevent an unintended pregnancy.
| ||||||
22 | (f) (c) Nothing in this Section shall be construed to | ||||||
23 | require an insurance
company to cover services related to an | ||||||
24 | abortion as the term "abortion" is
defined in the Illinois | ||||||
25 | Abortion Law of 1975.
| ||||||
26 | (d) Nothing in this Section shall be construed to require |
| |||||||
| |||||||
1 | an insurance
company to cover services related to permanent | ||||||
2 | sterilization that requires a
surgical procedure.
| ||||||
3 | (Source: P.A. 95-331, eff. 8-21-07.)
|